课题基金 / 基金详情

项目摘要

项目成果

Heidi Kong的其他基金

相似基金

相关文献

中文摘要
翻译
我们一直在积极招募临床试验方案的安全性和有效性外用罗米地辛(抑郁肽)治疗早期蕈样真菌病(一种罕见的皮肤淋巴瘤)。在2008财政年度,我们完成了两个剂量水平。每个剂量水平评估包括通过体格检查反复评估皮肤病、药物耐受性、瘙痒、生活质量、使用色度计的红斑、使用标准化工作室设置的摄影、研究血液以评估副作用和药代动力学,以及进行常规组织学和特殊研究的皮肤活检。
英文摘要
We have been actively recruiting for this clinical trial protocol of the safety and efficacy of topical romidepsin (depsipeptide) in early stage mycosis fungoides (a rare type of skin lymphoma). In fiscal year 2008, we completed two dose levels. Each dose level evaluation includes repeated assessments of skin disease through physical examination, medication tolerability, pruritus, quality of life, erythema with the use of colorimeter, photography using a standardized studio set-up, research blood for side effect evaluation and pharmacokinetics, and skin biopsies for routine histology and special research studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of systemic and topical perturbations on human microbes
Botulinum Toxin for Painful Cutaneous Leiomyomas
Gene Expression Profiling and Clinical Characterization of Phototoxicity
Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients
海外基金